Clinical Trial Update: Almond Dose Response Study. [Phase 2]

View source ↗

Summary

Phase 2 almond dose-response trial completed in individuals with hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hyperlipidemia

Snippet

Sponsor: University of Toronto | Conditions: Hyperlipidemia, Diet Therapy | Phase 2 | Status: COMPLETED